Xeris Biopharma Holdings: Q1 Earnings Insights

Xeris Biopharma Holdings XERS reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Xeris Biopharma Holdings reported in-line EPS of $-0.25 versus an estimate of $-0.25.

Revenue was up $13.86 million from the same period last year.

Last quarter the company missed on EPS by $0.18 which was followed by a 3.05% increase in the share price the next day.

Here's a look at Xeris Biopharma Holdings's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.24	-0.37	-0.30	-0.34
EPS Actual	-0.42	-0.39	-0.41	-0.30
Revenue Estimate	18.90M	11.03M	9.54M	7.47M
Revenue Actual	21.43M	11.04M	8.84M	8.05M

To track all earnings releases for Xeris Biopharma Holdings visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar